XELJANZ 1 mg/mL
tofacitinib · SOLUTION · Pfizer Laboratories Div Pfizer Inc
Xeljanz (tofacitinib) is an oral solution used to treat rheumatoid arthritis and certain other inflammatory conditions. It works by modulating the immune system to reduce inflammation and symptoms associated with these diseases.
Key Facts
- Brand Name
- XELJANZ
- Generic Name
- tofacitinib
- NDC Code (Product)
0069-1029- Manufacturer
- Pfizer Laboratories Div Pfizer Inc
- Strength
- 1 mg/mL
- Dosage Form
- SOLUTION
- Route
- ORAL
- Marketing Status
- Application #
- NDA213082
- Marketing Start
- 02/08/2021
Recall History
No Recall HistorySide Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Frequently Asked Questions
What is XELJANZ used for?
Xeljanz (tofacitinib) is an oral solution used to treat rheumatoid arthritis and certain other inflammatory conditions. It works by modulating the immune system to reduce inflammation and symptoms associated with these diseases.
Is XELJANZ a controlled substance?
XELJANZ is not classified as a controlled substance by the DEA.
What is the generic name for XELJANZ?
The generic name for XELJANZ is tofacitinib. There are 9 other brand versions of tofacitinib.
What is the NDC code for XELJANZ 1 mg/mL?
The NDC (National Drug Code) for XELJANZ 1 mg/mL is 0069-1029, listed by Pfizer Laboratories Div Pfizer Inc.